Literature DB >> 8449828

Artificial pneumothorax as a risk factor for development of pleural lymphoma.

K Aozasa1, M Ohsawa, K Iuchi, K Tajima, H Komatsu, M Shimoyama.   

Abstract

An etiologically important role of chronic tuberculous empyema for development of pleural lymphocytic lymphoma of B-cell type has been suggested. To examine risk factors for development of pleural lymphoma in patients with chronic tuberculous empyema, a case-control study was carried out. Onset age of lung tuberculosis and empyema, presence of chemotherapy, surgical treatment, extent of empyema, presence of fistula, history of smoking, and height and weight of patients at first admission were compared in patients with empyema alone (70 controls) and empyema complicated with lymphoma (42 cases): the date of birth and sex were matched by group. The patients receiving artificial pneumothorax showed a significant increase in risk for development of pleural lymphoma (relative risk = 4.92, P < 0.05). We could not find any report describing development of pleural neoplasias in patients with chronic empyema receiving surgical resection of pleural pyogenic membrane. From these findings, it is suggested that artificial pneumothorax left chronic non-healing inflammation in the pleural cavity, which resulted in development of pleural lymphoma.

Entities:  

Mesh:

Year:  1993        PMID: 8449828      PMCID: PMC5919033          DOI: 10.1111/j.1349-7006.1993.tb02784.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  7 in total

1.  The association of pleural mesothelioma and tuberculosis.

Authors:  G C Roviaro; F Sartori; F Calabrò; F Varoli
Journal:  Am Rev Respir Dis       Date:  1982-09

2.  Increased risk of lymphoma in sicca syndrome.

Authors:  S S Kassan; T L Thomas; H M Moutsopoulos; R Hoover; R P Kimberly; D R Budman; J Costa; J L Decker; T M Chused
Journal:  Ann Intern Med       Date:  1978-12       Impact factor: 25.391

3.  Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax.

Authors:  K Iuchi; A Ichimiya; A Akashi; T Mizuta; Y E Lee; H Tada; T Mori; K Sawamura; Y S Lee; K Furuse
Journal:  Cancer       Date:  1987-10-15       Impact factor: 6.860

4.  Soft tissue sarcoma of the pleural cavity.

Authors:  A Myoui; K Aozasa; K Iuchi; T Mori; S Yamamoto; S Kuratsu; M Ohsawa; K Ono; K Matsumoto
Journal:  Cancer       Date:  1991-10-01       Impact factor: 6.860

5.  Non-Hodgkin's lymphoma of the pleural cavity developing from long-standing pyothorax. Summary of clinical and pathological findings in thirty-seven cases.

Authors:  K Iuchi; K Aozasa; S Yamamoto; T Mori; K Tajima; K Minato; K Mukai; H Komatsu; T Tagaki; Y Kobashi
Journal:  Jpn J Clin Oncol       Date:  1989-09       Impact factor: 3.019

6.  Chronic thyroiditis as a risk factor of B-cell lymphoma in the thyroid gland.

Authors:  I Kato; K Tajima; T Suchi; K Aozasa; F Matsuzuka; K Kuma; S Tominaga
Journal:  Jpn J Cancer Res       Date:  1985-11

7.  National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project.

Authors: 
Journal:  Cancer       Date:  1982-05-15       Impact factor: 6.860

  7 in total
  5 in total

1.  Expression profile of human herpesvirus 8 (HHV-8) in pyothorax associated lymphoma and in effusion lymphoma.

Authors:  M O'Donovan; I Silva; V Uhlmann; N Bermingham; K Luttich; C Martin; O Sheils; A Killalea; C Kenny; S Pileri; J J O'Leary
Journal:  Mol Pathol       Date:  2001-04

Review 2.  Spectrum of Epstein-Barr virus-related diseases: a pictorial review.

Authors:  Eriko Maeda; Masaaki Akahane; Shigeru Kiryu; Nobuyuki Kato; Takeharu Yoshikawa; Naoto Hayashi; Shigeki Aoki; Manabu Minami; Hiroshi Uozaki; Masashi Fukayama; Kuni Ohtomo
Journal:  Jpn J Radiol       Date:  2009-02-08       Impact factor: 2.374

3.  Non-Hodgkin's lymphoma developing in a pacemaker pocket.

Authors:  Nobumasa Hojo; Yoshihiro Yakushijin; Hiroshi Narumi; Yoko Minamoto; Ikuya Sakai; Kiyonori Takada; Takaaki Hato; Masaki Yasukawa; Shigeru Fujita
Journal:  Int J Hematol       Date:  2003-05       Impact factor: 2.490

4.  Epidemiology and secular trends of malignant lymphoma in Japan: Analysis of 9426 cases according to the World Health Organization classification.

Authors:  Reiji Muto; Hiroaki Miyoshi; Kensaku Sato; Takuya Furuta; Hiroko Muta; Keisuke Kawamoto; Eriko Yanagida; Kyohei Yamada; Koichi Ohshima
Journal:  Cancer Med       Date:  2018-10-11       Impact factor: 4.452

5.  Primary diffuse large B-cell lymphoma as a chest-wall mass: A case report.

Authors:  Qianwen Zhang; Yuanrong Ju; Tao Qu; Tao Wang; Xiaoqin Liu
Journal:  Medicine (Baltimore)       Date:  2018-11       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.